Quick Answer
Connect Biopharma Holdings Ltd reported Total Assets of $56.08 million for the year ending 2025.
- Connect Biopharma Holdings Ltd showed a decrease of -44.6% in Total Assets from 2024 to 2025.
- This data is from Connect Biopharma Holdings Ltd's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2025: $92.69 million | Q2 2025: $82.73 million | Q3 2025: $67.36 million.
- Over the full 6 years of available data (2020 to 2025), Connect Biopharma Holdings Ltd's Total Assets has declined by 94.8%.
- Historical annual values: Fiscal year 2025: $56.08 million | Fiscal year 2024: $101.28 million | Fiscal year 2023: $127.38 million | Fiscal year 2022: $174.01 million | Fiscal year 2021: $291.05 million | Fiscal year 2020: $1.08 billion.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: